Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling
- PMID: 15557191
- DOI: 10.4049/jimmunol.173.11.6949
Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling
Abstract
TLRs have been implicated in recognition of pathogen-associated molecular patterns. TLR4 is a signaling receptor for LPS, but requires MD-2 to respond efficiently to LPS. The purposes of this study were to examine the interactions of the extracellular TLR4 domain with MD-2 and LPS. We generated soluble forms of rTLR4 (sTLR4) and TLR2 (sTLR2) lacking the putative intracellular and transmembrane domains. sTLR4 consisted of Glu(24)-Lys(631). MD-2 bound to sTLR4, but not to sTLR2 or soluble CD14. BIAcore analysis demonstrated the direct binding of sTLR4 to MD-2 with a dissociation constant of K(D) = 6.29 x 10(-8) M. LPS-conjugated beads precipitated MD-2, but not sTLR4. However, LPS beads coprecipitated sTLR4 and MD-2 when both proteins were coincubated. The addition of sTLR4 to the medium containing the MD-2 protein significantly attenuated LPS-induced NF-kappaB activation and IL-8 secretion in wild-type TLR4-expressing cells. These results indicate that the extracellular TLR4 domain-MD-2 complex is capable of binding LPS, and that the extracellular TLR4 domain consisting of Glu(24)-Lys(631) enables MD-2 binding and LPS recognition to TLR4. In addition, the use of sTLR4 may lead to a new therapeutic strategy for dampening endotoxin-induced inflammation.
Similar articles
-
Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.J Immunol. 2006 Dec 1;177(11):8133-9. doi: 10.4049/jimmunol.177.11.8133. J Immunol. 2006. PMID: 17114488
-
The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.Biochem Biophys Res Commun. 2005 Mar 11;328(2):586-90. doi: 10.1016/j.bbrc.2005.01.021. Biochem Biophys Res Commun. 2005. PMID: 15694388
-
Endotoxin recognition molecules MD-2 and toll-like receptor 4 as potential targets for therapeutic intervention of endotoxin shock.Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):291-7. doi: 10.2174/1568010043343633. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15379597 Review.
-
Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction.J Biol Chem. 2003 Nov 28;278(48):48313-20. doi: 10.1074/jbc.M306802200. Epub 2003 Sep 5. J Biol Chem. 2003. PMID: 12960171
-
Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes.J Endotoxin Res. 2000;6(5):401-5. doi: 10.1179/096805100101532243. J Endotoxin Res. 2000. PMID: 11521063 Review.
Cited by
-
Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling.Front Immunol. 2022 Dec 1;13:1023567. doi: 10.3389/fimmu.2022.1023567. eCollection 2022. Front Immunol. 2022. PMID: 36531997 Free PMC article. Review.
-
Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection.Front Microbiol. 2022 Mar 3;13:821066. doi: 10.3389/fmicb.2022.821066. eCollection 2022. Front Microbiol. 2022. PMID: 35308376 Free PMC article.
-
Potential Role of Soluble Toll-like Receptors 2 and 4 as Therapeutic Agents in Stroke and Brain Hemorrhage.Int J Mol Sci. 2021 Sep 15;22(18):9977. doi: 10.3390/ijms22189977. Int J Mol Sci. 2021. PMID: 34576137 Free PMC article. Review.
-
Toll-Like Receptors: General Molecular and Structural Biology.J Immunol Res. 2021 May 29;2021:9914854. doi: 10.1155/2021/9914854. eCollection 2021. J Immunol Res. 2021. PMID: 34195298 Free PMC article. Review.
-
Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients.Contemp Oncol (Pozn). 2020;24(4):216-220. doi: 10.5114/wo.2020.102818. Epub 2021 Jan 4. Contemp Oncol (Pozn). 2020. PMID: 33531868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials